- Sep 25, 2018

VTE Risk Persists Lifelong for Childhood Cancer Survivors

Childhood cancer survivors have an increased risk for venous thromboembolism (VTE) that persists across their lifespan, according to results from the multi-institutional Childhood Cancer Survivor Study (CCSS) cohort of more than 24,000 5-year survivors and 5,000 siblings.

Pediatric Cancer Survivors Treated With Abdominopelvic RT Have Higher Risk of CRC

Study shows potential of new treatment strategies for most common childhood cancer

Promising target for CAR T cells helps cancer trick the immune system

Palliative Care Important for Young Patients During ‘Identity Development’

Scientists discover new Achilles heel of leukemia cells

Promising investigational therapy improves survival in aggressive childhood brain tumor

Childhood cancer mortality has fallen significantly in the US, but disparities have emerged

St. Jude scientists identify T-cell differentiation nodes to improve cancer-killing

Analysis shows high rate of ‘significant’ health problems in childhood cancer survivors

Fusion oncoprotein forces cell fates toward rhabdomyosarcoma

Recent Posts

VTE Risk Persists Lifelong for Childhood Cancer Survivors

Archive

Search By Tags